ATE185698T1 - Therapeutisches agens - Google Patents

Therapeutisches agens

Info

Publication number
ATE185698T1
ATE185698T1 AT94918690T AT94918690T ATE185698T1 AT E185698 T1 ATE185698 T1 AT E185698T1 AT 94918690 T AT94918690 T AT 94918690T AT 94918690 T AT94918690 T AT 94918690T AT E185698 T1 ATE185698 T1 AT E185698T1
Authority
AT
Austria
Prior art keywords
inflammatory
xii
mixtures
compound
plant extracts
Prior art date
Application number
AT94918690T
Other languages
English (en)
Inventor
Brian Daunter
Original Assignee
Main Camp Marketing Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Main Camp Marketing Pty Ltd filed Critical Main Camp Marketing Pty Ltd
Application granted granted Critical
Publication of ATE185698T1 publication Critical patent/ATE185698T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT94918690T 1993-06-25 1994-06-24 Therapeutisches agens ATE185698T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPL960593 1993-06-25

Publications (1)

Publication Number Publication Date
ATE185698T1 true ATE185698T1 (de) 1999-11-15

Family

ID=3777003

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94918690T ATE185698T1 (de) 1993-06-25 1994-06-24 Therapeutisches agens

Country Status (12)

Country Link
EP (1) EP0708651B1 (de)
JP (1) JPH09505024A (de)
CN (1) CN1129908A (de)
AT (1) ATE185698T1 (de)
CA (1) CA2165794A1 (de)
DE (1) DE69421280T2 (de)
ES (1) ES2140541T3 (de)
IN (1) IN178310B (de)
NZ (1) NZ267567A (de)
PL (1) PL176595B1 (de)
WO (1) WO1995000157A1 (de)
ZA (1) ZA944568B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9821670D0 (en) * 1998-10-05 1998-12-02 Muhlbauer Roman C Plant extracts for the treatment of increased bone resorption
US6352728B1 (en) 1999-11-02 2002-03-05 International Celery Development Alliance Pty. Ltd. Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation
AUPP797598A0 (en) * 1998-12-30 1999-01-28 Butters, Desley Therapeutic agent
GB0211943D0 (en) * 2002-05-23 2002-07-03 Univ Sheffield Anti-helicobacter activity of celery seed components
US20070082947A1 (en) * 2003-05-14 2007-04-12 D Orazio Daniel Use of phthalide derivatives for the treatment and prevention of diabetes mellitus
JP2007505854A (ja) 2003-09-23 2007-03-15 ディーエスエム アイピー アセッツ ビー.ブイ. 糖尿病の治療および予防用組成物
CN1257711C (zh) * 2003-12-05 2006-05-31 石药集团中奇制药技术(石家庄)有限公司 丁苯酞软胶囊及其制备工艺
WO2006125651A2 (en) * 2005-05-24 2006-11-30 Dsm Ip Assets B.V. Ligustilide derivatives for the treatment of inflammatory disorders
JP2010500386A (ja) * 2006-08-11 2010-01-07 ディーエスエム アイピー アセッツ ビー.ブイ. 中枢神経系の障害を治療するためのリグスチリド誘導体
CN100569241C (zh) * 2007-01-17 2009-12-16 北京天川军威医药技术开发有限公司 芹菜籽乙酸乙酯萃取物及其用途
US8722338B2 (en) 2009-03-11 2014-05-13 The Johns Hopkins University Modulation of ABCG2-mediated urate transport to treat hyperuricemia and gout
EP2504007B1 (de) * 2009-11-23 2018-04-11 BAGI Research Limited Neue therapeutische verfahren zur behandlung von entzündungs- und autoimmunerkrankungen
JP5581120B2 (ja) * 2010-06-07 2014-08-27 花王株式会社 電位依存性カチオンチャネル抑制剤
CN102697772A (zh) * 2012-05-08 2012-10-03 中国人民解放军第二军医大学 一种治疗痛风的药物组合物及其应用
CN103183654B (zh) * 2013-01-30 2014-11-05 泰山医学院 芹菜籽活性单体的分离纯化制备工艺
CN105535116A (zh) * 2015-12-23 2016-05-04 辽宁科技学院 一种天然药物提取物及其制备方法
KR102742339B1 (ko) 2017-04-21 2024-12-13 유니버시티 오브 타스마니아 치료 화합물 및 방법
KR20210133463A (ko) * 2020-04-29 2021-11-08 한국 한의학 연구원 시라 추출물을 유효성분으로 함유하는 골질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2334368A1 (fr) * 1975-12-10 1977-07-08 Unilever Nv Procede d'isolation, a partir des pepins de raisin, d'une substance a activite anti-inflammatoire, et composition pour la peau, contenant une telle substance
DE3040246C2 (de) * 1979-10-29 1985-01-10 Osaka Chemical Laboratory Co., Ltd., Osaka Sojasaponine A↓1↓ und A↓2↓ und ihre Verwendung
DE3347658A1 (de) * 1983-12-31 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln 1.4-naphthochinonderivate mit entzuendungshemmender wirkung
JPS61257155A (ja) * 1985-05-10 1986-11-14 Horiuchi:Kk 抗酸化食品
WO1987001698A2 (en) * 1985-09-20 1987-03-26 The Upjohn Company 1,4-naphthalenediol and 1,4-hydroquinone derivatives
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
FR2611502B1 (fr) * 1987-02-24 1990-03-09 Natura Medica Laboratoires Extrait de racines d'ombellifere obtenu par extraction hydroalcoolique, procede de preparation d'un tel extrait; et composition therapeutique, notamment a activite diuretique, cardiovasculaire, antalgique ou anti-inflammatoire comprenant un tel extrait
JPH02196767A (ja) * 1988-10-11 1990-08-03 Kyowa Hakko Kogyo Co Ltd ヒドロキサム酸誘導体
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
IT1242020B (it) * 1990-11-20 1994-02-02 Sigma Tau Ind Farmaceuti Ftalidilidene derivati della carnitina e di alcanoil carnitine e composizioni farmaceutiche che li contengono.
AU653024B2 (en) * 1991-05-30 1994-09-15 Novartis Ag Substituted diaminophthalimides and analogues

Also Published As

Publication number Publication date
PL176595B1 (pl) 1999-06-30
PL312714A1 (en) 1996-05-13
DE69421280D1 (de) 1999-11-25
DE69421280T2 (de) 2000-07-13
EP0708651A1 (de) 1996-05-01
ES2140541T3 (es) 2000-03-01
CA2165794A1 (en) 1995-01-05
EP0708651B1 (de) 1999-10-20
ZA944568B (en) 1995-03-20
CN1129908A (zh) 1996-08-28
IN178310B (de) 1997-03-22
WO1995000157A1 (en) 1995-01-05
JPH09505024A (ja) 1997-05-20
NZ267567A (en) 1997-10-24
EP0708651A4 (de) 1998-03-04

Similar Documents

Publication Publication Date Title
DE69421280D1 (de) Therapeutisches agens
NO962187D0 (no) Sammensetninger som inhiberer apoptose, fremgangsmåter for rensing av sammensetningene og anvendelse derav
NO992641L (no) Blandinger og fremgangsmåter for behandling eller forhindring av betennelsessykdommer
ES2144980T1 (es) Metodos y composiciones para tratar la rinitis alergica y otros trastornos, empleando descarboetoxiloratadina.
MX9301835A (es) Composiciones alimenticias de derivado de vitamina d y metodo de uso.
DE69827777D1 (de) Zusammensetzungen mit verzögerter Wirkstoffabgabe zur Behandlung der Hyperlipidämie
DE60329180D1 (de) Sebum- und schweissabsorbierendes grundierungsset und entsprechendes mehrstufiges verfahren
BR9908222A (pt) Composições para regular a aparência da pele
CA2232583A1 (en) Lipoic acid in topical compositions
MX168000B (es) Complemento dietetico que contiene beta-glucan complemento
EA200300906A1 (ru) Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7
MX9302968A (es) Composiciones de oxicodona de liberacion controlada.
EA200300703A1 (ru) Пищевая композиция, подходящая для поверхностного обжаривания, включающая лецитин подсолнечника
PT99597B (pt) Processo para a preparacao de derivados do acido hidroxamico que inibem a lipoxigenase
NO862409L (no) Preparat mot akner.
ATE185271T1 (de) Behandlung von durch talgdrüse verursachten erkrankungen mit inhibitoren der acyl coa cholesterin acyltransferase
ATE283044T1 (de) Compactin zur behandlung von entzündungen
UA10208A (uk) Дерматологічний косметичний засіб
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69708338D1 (de) Verfahren zur herstullung natürlicher 1,3 diol derivate und korrespondierende natürliche 1,3 dioxan derivate
ATE234614T1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
JPS5714517A (en) Whitening cosmetic
MX9302419A (es) Derivados de acido tetronico, tiotetronico y tetramico.
ES2100274T3 (es) Nuevos 2-sacarinilmetil y 4,5,6,7-tetrahidro-2-sacarinilmetil fosfatos, fosfonatos y fosfinatos utiles como inhibidores de enzimas proteoliticos y composiciones y metodos de empleo de los mismos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties